Equities

RaQualia Pharma Inc

4579:TYO

RaQualia Pharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)558.00
  • Today's Change-4.00 / -0.71%
  • Shares traded25.20k
  • 1 Year change-25.10%
  • Beta1.1706
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,9012,9182,776
OPERATING EXPENSES
Cost of revenue total245232321
Selling, general and admin. expenses, total614565615
Depreciation/amortization200148142
Unusual expense(income)226520
Other operating expenses, total0.000.000.00
Total operating expense2,2602,1172,088
Operating income(359)801688
Other, net11(16)8.63
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(294)851881
Provision for income taxes30128125
Net income after taxes(324)723756
Minority interest------
Net income before extra. Items(324)723756
Total extraordinary items------
Net income(324)723756
Inc.avail. to common excl. extra. Items(324)723756
Inc.avail. to common incl. extra. Items(324)723756
EPS RECONCILIATION
Basic/primary weighted average shares222121
Basic/primary eps excl. extra items(15)3436
Basic/primary eps incl. extra items(15)3436
Dilution adjustment------
Diluted weighted average shares222121
Diluted eps excl. extra items(15)3436
Diluted eps incl. extra items(15)3436
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental6.686.001.45
SUPPLEMENTAL INCOME
Depreciation, supplemental193148142
Total special items226520
NORMALISED INCOME
Normalized income before taxes(272)916900
Effect of special items on income taxes7.589.742.78
Income tax excluding impact of special items37137128
Normalized income after tax(310)779773
Normalized income avail. to common(310)779773
Basic normalized EPS(14)3737
Diluted normalized EPS(14)3737
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.